Constellation Capital Corp. is a Canada-based capital pool company. The principal business of the Company is to identify and evaluate assets or businesses with a view to acquire them or an interest therein by completing a purchase transaction.

Employees

Sector

Investment Holding Companies

More about the company

Income Statement and Estimates

More financial data

Market Closed - Toronto S.E. Other stock markets 09:30:00 21/01/2026 pm IST			5-day change	1st Jan Change
0.0700 ^CAD	-.--%		-.--%	-

02:51am	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/05	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	5L 3L 3L 3L 3L 3.23Cr 5L 32.81L 12.81L 1.6Cr 12.66L 12.39L 5.52Cr	P/E 2024	-7.49x	P/E 2025	-8.26x
Enterprise Value	-2L -1L -93.59T -87.12T -80.01T -1.02Cr -2L -10.36L -4L -50.41L -4L -4L -1.74Cr	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	90.67%	Yield 2024 *	-	Yield 2025	-

02:51am	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/05	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
09/02	Active Witness Corp. entered into letter of intent to acquire Constellation Capital Corp. (TSXV:CNST.P) in a reverse merger transaction for CAD 16.4 million.	CI
30/01	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11/11	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
15/25/15	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
24/25/24	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
24/25/24	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/25/17	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
17/25/17	300,000 Stock Options of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
30/24/30	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
22/24/22	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
20/24/20	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 20-JUL-2024.	CI

02/04	Constellation Announces Extension to Amalgamation Agreement with Active Witness Corp.	AQ
09/02	Constellation Announces Proposed Acquisition of Active Witness Corp.	AQ
14/11	Constellation Announces Extension Of LOI For The Proposed Acquisition Of Active Witness Corp.	AQ
30/25/30	Constellation Announces Proposed Acquisition Of Active Witness Corp.	AQ
29/25/29	Canadian Investment Regulatory Organization Trading Halt - CNST.P	AQ

Constellation Capital Corp. Share Price

Stocks

CNST.P

CA21036W1032

Investment Holding Companies

Valuation: Constellation Capital Corp.

Chart: Constellation Capital Corp.

Latest news : Constellation Capital Corp.

Press Releases: Constellation Capital Corp.

Course Extremes

Managers and Directors: Constellation Capital Corp.

Latest insider transactions

Shell Companies

Financials

Company Profile

Income Statement and Estimates

1 year	0.04	0.15
3 years	0.04	0.15
5 years	0.04	0.15
10 years	0.04	0.15

Director	Title	Age	Since
Dayton Marks BRD	Director/Board Member	33	27/07/2022
Roger Jewett BRD	Director/Board Member	63	01/01/2022
Robert Quinn BRD	Director/Board Member	70	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/12/24	Roger Jewett	Buy	Director	10,000	0.1471%
05/12/24	Roger Jewett	Buy	Director	50,000	0.7353%
05/12/24	Roger Jewett	Buy	Director	60,000	0.8824%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONSTELLATION CAPITAL CORP.	-.--%	-.--%	-.--%	-30.00%	3L
BOXABL INC.	-23.85%	-26.51%	-38.38%	-	1.47TCr
CHURCHILL CAPITAL CORP XI	+0.29%	-5.18%	-	-	76Cr
CENTIEL AG	+1.81%	+21.22%	+306.02%	-65.44%	66Cr
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.05%	+0.25%	-	-	64Cr
DEEP FISSION, INC.	-4.58%	-8.08%	-	-	62Cr
CHURCHILL CAPITAL CORP XII	-0.92%	+0.09%	-	-	61Cr
CANTOR EQUITY PARTNERS IV, INC.	-0.57%	+0.05%	-	-	60Cr
BAIN CAPITAL GSS INVESTMENT CORP.	+0.06%	+0.20%	-	-	60Cr
Average	-2.83%	-2.43%	+89.21%	-47.72%	213.54Cr
Weighted average by Cap.	-18.32%	-25.55%	-23.58%	-65.42%

	2024	2025
Net sales	-	-
Net income	-45.38T -32.16T -28.27T -26.32T -24.17T -30.84L -45.98T -3L -1L -15.23L -1L -1L -52.63L	-57.62T -40.83T -35.89T -33.41T -30.68T -39.15L -58.38T -4L -2L -19.33L -2L -1L -66.82L
Net Debt	-7L -5L -4L -4L -4L -4.61Cr -7L -46.79L -18.27L -2.28Cr -18.06L -17.67L -7.87Cr	-6L -4L -4L -4L -3L -4.26Cr -6L -43.16L -16.86L -2.1Cr -16.66L -16.3L -7.26Cr